Biotech has been confusing me lately ngl. $MRNA  is trying so hard to prove it’s not just a pandemic one-hit wonder, and $LLY is basically carrying the whole sector on its Ozempic/Wegovy energy while everything else moves in slow motion. And then there’s $CRSP popping off every time someone mentions gene editing like it’s sci-fi becoming real. I can’t tell if biotech is low-key setting up for a glow-up or if we’re all just coping through the volatility. Anyone else watching this space? Are you buying dips or waiting till the sector stops acting like a reality show?